Eagle Pharmaceuticals, Inc.

XTX Topco Ltd EGRX
Report date
12/31/2024
Quarter
2024 Q4
Filed
2/13/2025
Shares
23,594
Value ($000)
12
Weight
0.0%
2023 Q3 - 2024 Q4 (5 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).